Darunavir is a potent second-generation HIV protease inhibitor used in the treatment of HIV-1 infection, typically administered in combination with ritonavir or cobicistat to improve its pharmacokinetic… Read more



![Chemical structure of N-[(1R,2S)-2-Hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1-(phenylmethyl)propyl]carbamic Acid 1,1-Dimethylethyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1005324-46-8-N-1R2S-2-Hydroxy-3-2-methylpropyl4-nitrophenylsulfonylamino-1-phenylmethylpropylcarbamic-Acid-11-Dimethylethyl-Ester.png&w=3840&q=75)
![Chemical structure of N-[(1S,2R)-2-Hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1-(phenylmethyl)propyl]carbamic acid (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F799241-76-2-N-1S2R-2-Hydroxy-3-2-methylpropyl4-nitrophenylsulfonylamino-1-phenylmethylpropylcarbamic-acid-3r3as6ar-hexahydrofuro23-bfuran-3-yl-ester.png&w=3840&q=75)
![Chemical structure of N-[(1S,2S)-2-Hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1-(phenylmethyl)propyl]carbamic Acid 1,1-Dimethylethyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1133153-38-4-N-1S2S-2-Hydroxy-3-2-methylpropyl4-nitrophenylsulfonylamino-1-phenylmethylpropylcarbamic-Acid-11-Dimethylethyl-Ester.png&w=3840&q=75)


![Chemical structure of rel-(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl 4-nitrophenyl carbonate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F252873-35-1-rel-3R3aS6aR-Hexahydrofuro23-bfuran-3-yl-4-nitrophenyl-carbonate.png&w=3840&q=75)





Darunavir is a potent second-generation HIV protease inhibitor used in the treatment of HIV-1 infection, typically administered in combination with ritonavir or cobicistat to improve its pharmacokinetic profile. To ensure rigorous quality control and regulatory compliance, pharmaceutical laboratories utilize a comprehensive range of Darunavir reference standards, including synthetic intermediates, degradation products, and process-related impurities. These materials are essential for accurate impurity profiling, supporting the development and validation of sensitive analytical methods such as HPLC and LC-MS/MS. Furthermore, the inclusion of stable isotope labelled compounds provides critical internal standards for precise quantification in bioanalytical studies and pharmacopeial testing. By providing well-characterized benchmarks, these reference materials facilitate the identification and qualification of potential impurities, ensuring the safety, efficacy, and consistency of the final drug product throughout its development and manufacturing lifecycle.